The Origins of MLN: From Melon to Enzyme Finance
Melon, now known as Enzyme Finance, emerged in 2016 under the name Melonport AG, founded by Mona El Isa—a former Goldman Sachs vice president—and Reto Trinkler, a mathematician and decentralized systems expert. Their shared vision was to revolutionize traditional asset management by introducing a decentralized, blockchain-based infrastructure for creating and managing on-chain investment funds. The project aimed to deliver transparency, cost-efficiency, and accessibility in portfolio management, powered by its native token, MLN.
In February 2017, Melon executed a highly successful token sale, raising $2.9 million in just 10 minutes through an uncapped public offering. Notably, it avoided venture capital involvement, emphasizing community-driven funding. This early success laid the foundation for the protocol’s development and solidified MLN’s role as the central utility token.
A key milestone came in 2019 when control of the protocol was transferred from Melonport AG to the Melon Council—a decentralized governance body built using Aragon. This handover underscored the team’s commitment to decentralization, though some critics questioned whether true decentralization had been achieved given the continued influence of early stakeholders.
In a strategic move to rebrand and expand its identity, Melon was officially rebranded to Enzyme Finance, reflecting a broader mission beyond simple fund management. Despite this evolution, the MLN token remained at the core of the ecosystem, adapting to new roles within the upgraded protocol.
How MLN Powers Enzyme Protocol
MLN is the native cryptocurrency of Enzyme Finance, a modular Ethereum-based protocol designed for decentralized asset management. It enables users to create, customize, and manage on-chain investment funds with full transparency and without intermediaries.
Core Functionalities of MLN
- Fund Creation and Management
Enzyme allows fund managers to set up customizable vaults with defined parameters such as fee structures, asset permissions, risk thresholds, and trading rules. These configurations are enforced through smart contracts, ensuring compliance and reducing counterparty risk. - On-Chain Operations
All fund activities—including deposits, withdrawals, trades, and performance reporting—occur directly on the Ethereum blockchain. This guarantees transparency but also exposes users to Ethereum’s gas fees, which can become prohibitive during network congestion. - Security via Rulesets
Funds operate under strict rulesets that limit asset types and trading behaviors. For example, only whitelisted tokens can be traded, minimizing exposure to volatile or fraudulent projects.
MLN Token Utility
MLN serves two primary purposes:
- Fee Payments: Users pay protocol fees in MLN for actions like fund creation or restructuring.
- Governance: MLN holders can stake their tokens to vote on proposals related to protocol upgrades, treasury allocations, and parameter changes.
Importantly, a portion of collected fees is used to buy back and burn MLN tokens, creating a deflationary pressure that aims to offset annual token issuance and support long-term value accrual.
Key Use Cases of MLN in DeFi
1. Decentralized Fund Infrastructure
MLN empowers individuals and institutions to launch non-custodial investment funds. Unlike traditional asset managers who control client assets, Enzyme ensures investors retain ownership while granting managers permissioned access—enhancing trust and reducing fraud risks.
👉 Explore how blockchain-based fund management platforms are lowering entry barriers for investors.
2. Transparent and Secure Portfolio Management
All transactions are recorded immutably on-chain, allowing real-time auditing. While this transparency strengthens accountability, it also exposes strategies to front-running or replication by competitors—a trade-off inherent in open financial systems.
3. Interoperability with DeFi Ecosystem
Enzyme integrates with leading DeFi protocols such as Aave (lending), Uniswap (trading), and Curve (stablecoin swaps), enabling funds to generate yield across multiple platforms. However, this reliance introduces systemic risks—if one integrated protocol suffers an exploit, dependent funds may face losses.
4. Governance Participation
Holders of MLN influence the future of Enzyme by voting on key decisions. This decentralized governance model promotes community ownership but faces challenges like low voter turnout and disproportionate influence from large token holders.
MLN Tokenomics: Supply, Inflation, and Value Flow
MLN operates under a capped supply model with controlled inflation tied to ecosystem needs. New tokens are minted annually to fund development and incentivize participation, while a portion of fees is used to buy back and burn MLN—balancing inflationary pressures.
- Burn Mechanism: Fees collected in various assets are converted into MLN via auctions and burned, reducing circulating supply.
- Staking & Voting: Users stake MLN to participate in governance, aligning incentives between long-term holders and protocol growth.
- Annual Issuance: A fixed percentage of new tokens is issued each year, sparking debate about sustainability if protocol activity doesn’t scale proportionally.
This hybrid model attempts to balance short-term usability with long-term value preservation—a delicate equilibrium common across many DeFi tokens.
Governance Model: Decentralization in Practice
Enzyme Finance utilizes an on-chain governance system where MLN holders submit and vote on proposals. This includes upgrades to smart contracts, integration of new DeFi protocols, and allocation of treasury funds.
Despite its decentralized design, governance faces several hurdles:
- Low Participation: Like many DAOs, voter turnout remains low, risking concentration of power among whales.
- Technical Complexity: Proposals often require deep understanding of smart contract mechanics, deterring casual participants.
- Upgrade Risks: While governance enables agility, poorly vetted changes could introduce vulnerabilities.
Nonetheless, the shift from centralized development to community-led evolution marks a significant step toward true decentralization.
Technical Roadmap and Future Developments
Enzyme continues to evolve technically, with recent upgrades like Sulu (V4) improving gas efficiency and expanding DeFi integrations. Key focus areas include:
- Layer 2 Scaling: Exploring ZK-rollups and optimistic rollups to reduce Ethereum gas costs and improve scalability.
- Cross-Chain Expansion: Investigating interoperability solutions to extend beyond Ethereum and support multichain asset management.
- Developer Experience: Enhancing documentation and tooling to lower the barrier for developers building on Enzyme.
However, challenges persist:
- Dependency on Ethereum’s L1 limits scalability.
- Cross-chain bridges introduce security risks.
- High complexity deters mainstream adoption.
Success will depend on resolving these bottlenecks while maintaining robust security and usability.
Comparing MLN with Other DeFi Protocols
MLN vs UNI (Uniswap)
While UNI powers a decentralized exchange focused on liquidity and trading, MLN specializes in portfolio construction and fund management. They serve different niches—MLN targets asset managers; UNI caters to traders and liquidity providers.
MLN vs SNX (Synthetix)
SNX enables synthetic asset creation (e.g., synthetic Bitcoin or gold), requiring overcollateralization. MLN does not rely on collateral but instead facilitates diversified investment strategies across real assets.
MLN vs CRV (Curve Finance)
CRV optimizes stablecoin swaps with minimal slippage and rewards liquidity providers via veCRV staking. In contrast, MLN supports active fund strategies across volatile assets but lacks CRV’s widespread liquidity integration.
Each protocol excels in its domain—MLN stands out for its focus on structured, customizable fund management in DeFi.
Frequently Asked Questions (FAQ)
Q: What is the primary function of the MLN token?
A: MLN is used to pay protocol fees for fund creation and management operations on Enzyme Finance. It also grants governance rights when staked.
Q: Is Enzyme Finance only for professional investors?
A: While designed with sophisticated users in mind, anyone can create or invest in funds. However, technical knowledge improves effectiveness.
Q: How does MLN control inflation?
A: Through a burn mechanism—protocol fees are converted into MLN and destroyed, counteracting annual token issuance.
Q: Can I use Enzyme on blockchains other than Ethereum?
A: Currently, Enzyme operates primarily on Ethereum, but Layer 2 and cross-chain expansions are under active development.
Q: Is my money safe in an Enzyme-managed fund?
A: Funds are non-custodial and governed by smart contract rulesets, reducing counterparty risk. However, smart contract vulnerabilities remain a potential threat.
Q: How do I participate in Enzyme governance?
A: Stake your MLN tokens to vote on proposals related to protocol upgrades, integrations, and treasury usage.
Final Thoughts on MLN's Role in DeFi
MLN represents a bold experiment in decentralized asset management—one that combines institutional-grade fund structuring with blockchain transparency. Though adoption has been limited by complexity and competition, its modular design offers unmatched flexibility for advanced DeFi strategies.
As Layer 2 scaling matures and user interfaces improve, Enzyme Finance may find broader appeal beyond niche fund managers. For now, MLN remains a powerful tool for those seeking control, transparency, and innovation in crypto investing.